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INTRODUCTION 
Enzymes are widely used as medication in thrombolytic 
therapy [1, 2]. The “golden molecule” of fibrinolysis and 
“golden time” of thrombolysis are known to increase 
the arsenal of biocatalysts used in treatment [3, 4]. 
However, the therapeutic applications of enzymes are 
far from having been exhausted, and there is a search 
for new forms that can be used in the development of 
original treatments for various pathologies [5, 6].
It is widely known today that the development of 
many pathologies is accompanied by oxidative stress 
[7, 8]. Normally, reactive oxygen species (ROS) partici-
pate in cellular signaling. However, the distortion of the 
balance between oxidative and antioxidant activity, as 
well as the mass production of ROS, results in oxidative 
stress. Excess ROS in the organism leads to the modi-
fication of macromolecules, disbalance of metabolic 
pathways and progression of the pathologic processes 
[9] that can be prevented or delayed by means of anti-
oxidant administration [10]. Enzymes are considered as 
very efficient antioxidants, since they are specific and 
their mode of action is known in most cases [11]. Oxi-
dative stress is known to play an important role in the 
pathogenesis of most cardiovascular disorders, which 
is why many cardiology studies are focused on antioxi-
dants. 
Current views hold that superoxide dismutase, cata-
lase, and glutathione peroxidase are the main antioxi-
dant enzymes of the body. The autonomous functioning 
of the first two makes them attractive in terms of the 
development of antioxidant medication to protect the 
cardiovascular system against oxidative stress. Based 
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on the described advantages, we chose Cu,Zn-super-
oxide dismutase (SOD), and catalase for the develop-
ment of an enzymatic antioxidant derivate. 
Our approach was based on biochemical coupling 
of SOD and CAT activity, when the product of SOD-
reaction (H2O2) is used as a substrate by CAT, which 
finally yields water and oxygen as products [9, 11]. Ac-
cumulation of a glycosaminoglycan of endothelial gly-
cocalyx – chondroitin sulfate (CHS) – in zones of initial 
atherosclerotic changes of vessels (i. e. in sites of po-
tential damage of the vascular wall) [12] allowed the 
use of CHS as a cross-linking modifier of the enzyme 
subunits [13]. The water-soluble form of the obtained 
exogenic enzymatic conjugate SOD-CHS-CAT can be 
administered intravenously and per orally. It should 
be noted that the dimensions of a CAT molecule are 
10.5 × 10.5 × 5.0 nm [14], and they are 6.7 × 3.6 × 3.3 nm 
for a SOD molecule [15]. The polymer chain of CHS 
winds around the enzymatic subunits and connects 
them, thus forming a covalent conjugate, which was 
confirmed by means of electrophoresis under dena-
turing conditions [13, 16]. Moreover, the conjugate is 
more active in vivo than combinations of individual 
components, which are accounted for by its optimal in-
travascular distribution and higher action efficiency 
[17]. Based on its dimensions ─ (17–20) × (14–18) × (8–12) 
– the conjugate occupies the lower zone of the nano-
scale and, therefore, can be considered a nanoparticle. 
It is thought that the physical, chemical, and biological 
properties of molecular objects with nano-dimensions 
would surprisingly differ from the properties of their 
individual components, in part due to their quantum-
mechanical effects.
Considering the supramolecular SOD-CHS-CAT 
conjugate, a bienzymatic nano-device, in the current 
work we studied its interactions with platelets (occur-
ring in the blood stream) and with a ring arterial frag-
ment (occurring on the surface of the vascular wall). 
We also studied the properties of the supramolecular 
conjugate at the level of the organism in laboratory 
animals, both under conditions of oxidative stress as 
modeled by infusion of hydrogen peroxide, and under 
stress-free conditions.
EXPERIMENTAL PROCEDURES
Materials
In the present study, we used the following reagents: 
Cu,Zn-superoxide dismutase (SOD), isolated from bo-
vine red blood cells (specific activity 3,000 U/mg pro-
tein); catalase (CAT) from bovine liver (specific activity 
11,000 U/mg protein); chondroitin-4-sulfate A (mo-
lecular weight 25-50 kDa) from bovine trachea; ben-
zoquinone, dimethylformamide, β-galactosidase (from 
Escherichia coli), xantine, hydrogen peroxide, nora-
drenaline (NA), Nω-nitro-L-arginine (L-NNA), acetyl-
choline, sodium nitroprusside (SNP) were purchased 
from Sigma, USA. Xantinoxidase was purchased from 
Calbiochem (USA), nitrotetrazolium blue - from Reanal 
(Hungary), sephadex G-25 and sephacryle S-300 - from 
Pharmacia (Sweden). The other reagents were of ana-
lytical grade purity and manufactured in Russia.
Bienzyme SOD-CHS-CAT conjugate was obtained 
as previously described [16]. The protein content in a 
SOD-CHS-CAT preparation was 4-6% weight, specific 
SOD activity was 60 U/mg solid, and CAT - 140 U/mg 
solid. For preparation of the SOD-CHS-CAT conjugate 
with irreversibly inactivated enzymes, SOD and CAT 
were preliminarily incubated in the presence of 0.3 M 
hydrogen peroxide (pH 7.0, 0.02 М phosphate buffer, 3 
hours at room temperature) and at pH 11.8-12.0 (0.05 
M NaOH, 2 hours at room temperature), respectively 
[16].
Methods
Biochemical measurements. The protein content in 
preparations was determined by the Bradford method. 
The enzymatic activity of SOD was measured as inhi-
bition of reduction of nitrotetrasolium blue in the sys-
tem xantine-xantinoxidase, pH 7.8 [13]. CAT activity 
was determined spectrophotometrically as a decrease 
in absorption at λ=240 nm (disappearance of hydrogen 
peroxide; pH 7.0, room temperature) [16].
Studies on platelet aggregation. In order to investigate 
the effects of hydrogen peroxide and SOD-CHS-CAT 
on platelet aggregation, we used the blood of volun-
teers, which was taken from the ulnar vein and stored 
in plastic tubes containing 0.13 M sodium citrate (pH 
7.3). Platelet-rich plasma (PRP) was obtained by cen-
trifugation of blood samples at 180g for 15 min. Plate-
let aggregation was estimated by means of the laser 
two-channel aggregation analyzer BIOLA (LA 230-2 
model, NPF Biola, Russia). Apart from the customary 
approach based on registration of light transmission 
(Born’s method), platelet aggregation was measured 
based on the analysis of fluctuations of the light trans-
mission. The relative value of these fluctuations is pro-
portional to the average radius of aggregates and al-
lows to study the formation of micro-aggregates; i. e., 
those containing less than 100 platelets. It also allows 
the omission of the possible uncertainties that arise 
from light absorption by plasma and changes in plate-
let shape, which is of primary importance in studies of 
spontaneous aggregation.
The ability to form small-sized aggregates (3-100 
platelets) was estimated by measuring both spontane-
ous aggregation and aggregation induced by the addi-84 | ACTA NATURAE |  VOL. 2  № 4 (7)  2010
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tion of 0.5 μM ADP, 0.5 μM serotonine and 1.0 μM TRAP 
(thrombin receptor-activation peptide) by the method 
of registration of the avarage size of the aggregates (in 
relative units). The formation of large aggregates (more 
than 100 platelets) in response to the addition of 5.0 μM 
ADP and 6.0 μM TRAP was estimated by the Born’s 
method in % light transmission. Measurements were 
carried out during 2 hours after blood samples were 
obtained in 0.3 ml cuvettes.
Platelet adhesion was estimated by means of elec-
tronic microscopy. A 15 μM sample was mixed with 
a saline solution, H2O2 and/or CAT preparations and 
loaded onto an adhesive surface (glass), incubated 15 
minutes at room temperature in an enclosed space for 
preventing drying-out, rinsed with saline to wash the 
unattached platelets off and fixed by 2.5% glutaralde-
hyde for 1.5 hours. After fixation, the samples were de-
hydrated and prepared for electron microscopy.
Platelets of various shapes were quantified on 25 
scanning fields at a magnification of 2500x (PHILLIPS 
PSEM 550x scanning electron microscope). Adhesion 
was expressed as a percentage of platelets stuck to the 
surface.
Investigation of changes in tone of rat ring arterial 
fragment. After the decapitation of Wistar rats (males, 
350-400 g), the abdominal cavity was opened and ab-
dominal aorta was isolated. The isolated aortal seg-
ment was cleared from connective tissue and sliced 
into ring fragments 3 mm in length. Aortal fragments 
were then put on stainless needles connected to the 
tensosensor (which measures the mN forces produced 
by the arterial fragment) and placed into a Krebs-
Henseleit buffer insufflated with carbogenum at 37oC 
and pH 7.4 [18]. Oxidative stress was modeled by the 
addition of hydrogen peroxide to the preparation pre-
viously subjected to NA preconstriction (preliminary 
constriction of the arterial fragment induced by the 
addition of NA prior to another stimulus). Alteration 
of vascular tone was estimated relative to the level 
of contraction induced by 0.1 μM NA taken as 100%. 
Various concentrations of  antioxidant enzyme deriva-
tives were added 10 minutes before the addition of 
hydrogen peroxide against a background of NA-pre-
constriction. The production of endogenous NO and its 
influence on the tone of the ring arterial fragment was 
initiated by the addition of the exogenous inhibitor of 
NO-syntase L-NNA (0.1 μM).
Experiments in vivo. Tolerance and the protective ac-
tion of the SOD-CHS-CAT conjugate under conditions 
of H2O2-induced oxidative stress were studied in male 
rabbits (n=29) 3.65±0.10 kg in weight and male Wistar 
rats (n=13) 427±7g in weight. All animals were anaes-
thetized prior to the experiments by infusion of keta-
mine.
In  rabbits  undergoing  ketamine  narcosis 
(50-60 mg/kg weight), catheters (PE-50 diameter) were 
placed in the central artery of one ear and the marginal 
veins of both ears. After the initial narcosis, (55 mg/kg) 
5% ketamine was infused with a syringe pump (SAGE 
Instruments, USA) at a rate of 36-54 μl/hour per 1 kg 
of weight. The vein of the other ear was bolus-infused 
with saline or SOD-CHS-CAT solution, and 0.8% hy-
drogen peroxide solution at a rate of 0.4 ml/min for 
3 min, performed twice with a 20 min interval, which 
was necessary for full recovery of parameters after the 
first injection of hydrogen peroxide and distribution of 
the conjugate in the body. In the acute experiment, the 
infusion of reagents was done in the following order: 
hydrogen peroxide - saline solution (control group) or 
SOD-CHS-CAT (experiment group) - hydrogen perox-
ide. Registration of the mean blood pressure (BP), heart 
rate (HR) and electrocardiogram (ECG) in the second 
lead was carried out on BIOGRAF-4 (Saint-Petersburg 
State University of Aerospace Instrument Making, 
Russia) equipped with an ADC board NI 6210 (National 
Instruments, USA). Physiological signals were proc-
essed using corresponding software (Dr. E.V. Lukosh-
kova). After the registration of initial BP, HR and ECG 
(during 15 min) animals were infused with hydrogen 
peroxide (3 min) and the aforementioned physiological 
parameters were measured again during 10 minutes. 
The total dose of hydrogen peroxide injected through-
out the experiment was 0.31 μM/kg. The number of 
animals in the control group was 12; in the experimen-
tal group - 15.
In Wistar rats under ketamine narcosis (100 mg/kg), 
catheters (PE-50) were placed in the carotid artery and 
jugular vein. The protocol of the experiment was essen-
tially similar to the abovementioned, but with a minor 
difference: the time of hydrogen peroxide infusion was 
extended by 2 minutes in order to obtain similar effects 
on hemodynamic. The total dose of hydrogen peroxide 
injected in rats was 4.5 μM/kg. No animals died in the 
course of these experiments. 
A separate series of experiments on rabbits (n=8) 
was focused on the investigation of tolerance of vari-
ous doses of the SOD-CHS-CAT conjugate (therapeutic 
– 1.5 mg/kg and also 7.5 and 15 mg/kg). HR, BP, and 
ECG parameters were measured in these experiments. 
After a 15-minute control registration of BP, HR (taken 
as 100%), and ECG, the first dose of SOD-CHS-CAT 
(1.5 mg/kg ) was injected and HR, BP, and ECG were 
registered during 15 min. Afterward, the next dose of 
SOD-CHS-CAT (7.5 mg/kg) was injected, followed by 
the registration of hemodynamic parameters. 20 min-
utes later, another (15 mg/kg) dose, ten times greater RESEARCH ARTICLES
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than the therapeutic dose, was administered and he-
modynamic parameters were measured. The animals 
that  received a total dose of SOD-CHS-CAT 16 times 
greater in 72 hours were used to estimate the preven-
tive effects of the bienzyme conjugate during oxidative 
stress (as described above).  This contrasts with the ef-
fects obtained in both acute and control experiments 
on animals that had not been administered anything 
beforehand. 
Statistical treatment of obtained results. The results 
obtained are presented as a mean value±standard 
error, where n is the number of animals. The two 
groups were compared using the two-sample Stu -
dent’s t-test (the statistical significance of the differ-
ences was estimated at p < 0.01). In the case of more 
than two comparison groups, the statistical calcula-
tions were carried out using the ANOVA ( p < 0.01) 
method. 
RESULTS AND DISCUSSION
The effects of SOD-CHS-CAT on platelets
Under normal conditions, hydrogen peroxide acts as 
an intra- and inter-cellular signaling molecule. In the 
concentration range of 20-50 μM, hydrogen peroxide 
has limited cytotoxicity for many cell types. Under 
physiological conditions, 50 μM concentration is con-
sidered high [19]. The addition of 50-2000 μM hydro-
gen peroxide in vitro led to an aggregation of platelets 
(Fig. 1). Scanning electronic microscopy showed that at 
the moment of maximum aggregation the aggregates 
consisted of tightly packed platelets in the core. How-
ever, the platelets were bound rather loosely on the pe-
riphery (Fig. 1B). By the 5th minute in the process, the 
average size of the aggregates had decreased and their 
structure had become so dense that it was impossible 
to distinguish discrete platelets (Fig. 1C). The decrease 
in the size of the aggregates could be explained by a 
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Fig. 1. Typical platelet aggregation curve induced by 50 μM – 2.0 mM hydrogen peroxide and composition of platelet 
aggregates in different stages of their formation. A: segregate platelets before aggregation, mainly, in discoid forms; 
B: sample of aggregation peak – aggregates consist of tight core in their center and weakly attached platelets on their 
periphery (friable structure of peripheral area has been shown on insert in magnified view); C: sample after five minutes 
of platelet aggregation – the size of aggregates is decreased, weakly attached platelets are absent on periphery, strong 
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dissociation of weakly bound platelets from aggregate 
clusters, as well as the consolidation of aggregate cores. 
The addition of 3,000 U native catalase to the cuvette of 
the aggregometer substantially lowered the aggrega-
tion induced by 300 μM hydrogen peroxide (Fig. 2). The 
SOD-CHS-CAT conjugate was shown to suppress ag-
gregation in a dose as low as 400 U CAT activity, show-
ing an increased dose-dependent antioxidant activity 
compared to CAT alone. Neither CAT nor CHS affects 
platelet aggregation. 
The presence of 300 μM H2O2 increased platelet acti-
vation, in terms of their aggregation, induced by various 
inducers (with varying mechanisms of action, i.e., ADP, 
serotonin and TRAP (Fig. 3)). The addition of 3,000 U 
CAT or 400 U CAT-activity of the SOD-CHS-CAT con-
jugate to PRP suppressed the activating effects of H2O2 
(curves 4 and 5 in Figs. 3A, 3B and 3C, respectively). Ap-
plication of the conjugate proves its increased antioxi-
dant activity, exceeding that of CAT. The effect dem-
onstrated dose-dependence and reached a maximum 
(which did not substantially change when increased 
doses were added to the cuvette) at 3,000 and 400 U CAT 
activity for CAT and SOD-CHS-CAT, respectively. 
Due to the catalase activity, the CAT and SOD-
CHS-CAT derivates suppressed the effects of H2O2 on 
platelets (Figs. 2 and 3). However, it was shown that 
the platelets themselves can produce ROS [20]. This is 
in line with the inhibiting effect of the SOD-CHS-CAT 
on ADP-induced platelet aggregation (Fig. 4). At the 
same time, the effect of the CAT-CHS derivate was 
quite moderate, and CAT did not possess it at all (data 
not shown). The anti-aggregate activity of the bien-
zyme conjugate was due to the presence of enzymatic 
activities (curves 1 and 2 in Fig. 4) and also to its unique 
supramolecular structure, mediated by CHS (curves 1 
and 3 in Fig. 4) [11, 17]. Indeed, β-galactosidase (similar 
in molecular size to SOD-CHS-CAT) used in the same 
experimental scheme in equimolecular protein concen-
trations did not inhibit the ADP-induced platelet ag-
gregation. 
The action of SOD-CHS-CAT was expressed in inhib-
iting ADP-, serotonin-, and TRAP-induced platelet ag-
gregation (all the inducers exploit different mechanisms 
of action and were used in different concentrations) (Fig. 
5). This is a new quality for the SOD-CHS-CAT conju-
gate, since the individual components lack it.
Platelet spreading on the adhesive surface is one of 
the critical stages of hemostasis, which induces a se-
quence of reactions, leading to thrombus formation. 
Platelet adhesion and spreading takes place during 
transferral to glass (Fig. 6A). In the presence of H2O2, 
the amount of spread platelets increases (Fig. 6B), but 
when SOD-CHS-CAT conjugate is transferred be-
forehand to the glass (Fig. 6C) or the PRP (Fig. 6D), no 
spread platelets are found in the sample. A similar situ-
ation can be observed when PRP and SOD-CHS-CAT 
are transferred to glass which had H2O2 added to it be-
forehand (Fig. 6E). When PRP and CAT are added, the 
amount of spread platelets decreases significantly (Fig. 
6F). We note that free CHS did not demonstrate anti-
aggregate inhibition with regard to hydrogen peroxide. 
It is probable that this effect of the bienzyme conjugate 
has something to do with its adhesive and antioxidant 
qualities, which allow it, on the one hand, to protect the 
surface from platelet adhesion, and, on the other, to 
neutralize H2O2, which strengthens adhesion and plate-
let spreading on glass. 
The results we obtained indicate that the bienzyme 
SOD-CHS-CAT conjugate expresses an antioxidant 
dose-dependent effect during induced platelet aggre-
gation in the presence of hydrogen peroxide. The anti-
aggregate activity of the SOD-CHS-CAT conjugate is 
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Fig. 2. Influence of hydrogen peroxide, CAT and 
SOD-CHS-CAT on platelet aggregation. Curve of spon-
taneous platelet aggregation (1), aggregation in presence   
of 300 μM hydrogen peroxide (2), addition of 3,000 U 
native CAT first, followed by 300 μM hydrogen peroxide 
(3),  addition of 400 U CAT activity of SOD-CHS-CAT first, 
followed by 300 μM hydrogen peroxide (4). RESEARCH ARTICLES
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Fig. 3. Influence of CAT and SOD-CHS-CAT on platelet aggregation induced by ADP (A), serotonin (B), and TRAP (C) in 
the presence of hydrogen peroxide. A: Platelet aggregation curves in the presence of 0.5 μM ADP (1), 300 μM hydro-
gen peroxide (2), 0.5 μM ADP, and 300 μM hydrogen peroxide (3); preventive administration of 3,000 U CAT and then 
0.5 μM ADP with 300 μM hydrogen peroxide (4); and preventive administration of 400 U of CAT activity  
of SOD-CHS-CAT and then 0.5 μM ADP with 300 μM hydrogen peroxide (5). B: Platelet aggregation curves in the 
presence of 0.5 μM serotonin (1), 300 μM hydrogen peroxide (2), 0.5 μM serotonin, and 300 μM hydrogen peroxide 
(3); preventive administration of 3,000 U CAT and then 0.5 μM serotonin with 300 μM hydrogen peroxide (4); and 
preventive administration of 400 U of CAT activity of SOD-CHS-CAT and then 0.5 μM serotonin with 300 μM hydrogen 
peroxide (5). C: Platelet aggregation curves in the presence of 1 μM TRAP (1), 300 μM hydrogen peroxide (2), 1 μM 
TRAP, and 300 μM hydrogen peroxide (3); preventive administration of 3,000 U CAT and then 1 μM TRAP with 300 μM 
hydrogen peroxide (4); and preventive administration of 400 U of CAT activity of SOD-CHS-CAT and then 0.5 μM TRAP 
with 300 μM hydrogen peroxide (5). Typical aggregation curves were representative of 4-5 experiments. 
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ADP (1), and preventive administration (in equimolar con-
centration) of corresponding 400 U CAT activity  
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SODinact-CHS-CAT (5). Typical aggregation curves were 
representative of 3-5 experiments. 
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reliably higher than that of other CAT derivates and 
is demonstrated in a wide range of conditions when 
platelet aggregation is stimulated by various inducers 
(ADP, serotonin, TRAP – all of which differ in terms of 
mechanisms of action), both with and without hydro-
gen peroxide. The latter is evidence of a new aspect of 
the anti-aggregate potential of SOD-CHS-CAT, absent 
in the native enzymes and free CHS, and determined 
by its molecular composition and size. These qualities 
of the bienzyme SOD-CHS-CAT nanoconjugate show 
that it has a promising future in biopharmaceutical de-
velopment for purposes of antioxidant therapy. They 
are also proof of the promises in using enzyme conju-
gates as medicinal agent. 
The change in the tone of a ring fragment of rat aorta
The effects of oxidative stress on the tone of a ring 
fragment of rat abdominal aorta were modeled by the 
addition of H2O2 against a background of NA precon-
striction. The latter made up 50-60% of the maximum 
possible contraction of the arterial fragment, which 
made it possible to measure both contraction and re-
laxation. The change in vascular tone was estimated 
relative to the contraction exhibited in response to 0.1 
μM NA, taken at a 100% range of interval (for the gra-
dation of the size of tone change), and at the baseline of 
the experiment as 0% (to indicate the direction of tone 
change, contraction or relaxation). Hydrogen perox-
ide caused a dose-dependent vascular contraction. At 
Fig. 5. Influence 
of SOD-CHS-CAT 
conjugate (400 U 
of CAT activity, 
curve 2) on plate-
let aggregation 
induced (curve 1) 
by: 0.5 μM (A) 
and 5.0 μM (D) 
ADP; 0.5 μM (B) 
and 5.0 μM (E) 
serotonin; 1 μM 
(C) and 6 μM (F) 
TRAP. Typical ag-
gregation curves 
were representa-
tive of 3-6 experi-
ments. Abscissa 
is time (minutes), 
ordinate is aver-
age size of platelet 
aggregates (in rel. 
units, A-C, E) or 
light transmission 
(%, D and F).
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Fig. 6. Electron microscopy picture of platelet adhesion 
on glass surface (Scanning Electron Microscope Phillips 
PSEM 550x, magnification x2500). Platelet adhesion on 
glass with addition to PRP: saline (physiological solution, 
A), hydrogen peroxide (B), SOD-CHS-CAT (D). Adhesion 
of platelets on glass preventively treated by SOD-CHS-
CAT and then the addition on the glass surface of the PRP 
with hydrogen peroxide (C); by hydrogen peroxide and 
then the addition on the glass surface of PRP with SOD-
CHS-CAT (E) or with native CAT (F).   
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a 0.01 mM concentration of H2O2, we observed a small 
(10-12%) tone increase. At a 0.1 mM H2O2, this increase 
was more (48-50%) with a subsequent decrease to the 
initial level of NA preconstriction (0-3% relaxation). 
At a 1.0 mM concentration of H2O2, there was a rapid 
contraction of the arterial fragment (88-90%), which 
was followed by a relaxation phase (68-70%). Thus, the 
model we presented revealed a dose-dependent effect 
of hydrogen peroxide and was suitable for an experi-
mental study of the effect of ROS on the tone of the 
vascular fragment. 
After triple washing and a 15-minute rest period, the 
vascular fragment was exposed to NA and hydrogen 
peroxide again at the concentrations used earlier (0.01-
0.1 mM). The level of functional activity of the vascular 
fragment during the second response decreased with 
the increase in hydrogen peroxide concentration, both 
in relation to the second addition of NA, as well as to 
the amount of contraction during the second addition 
of H2O2 (Fig. 7). The reliable decrease in the second 
contraction of the arterial fragment after the second 
addition of large concentrations of hydrogen peroxide 
serves as a measure of the invariability of vascular re-
actions. 
The addition of native CAT against the background 
of NA-induced preconstriction did not influence the 
vascular tone in any of the concentrations used. The 
reaction to the addition of 1.0 mM H2O2 in the presence 
of CAT decreased substantially in terms of contraction 
А
B
C
|First response| |Repeat response|
0.01 mM 
H2O2
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0.01         0.10        1.00
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Fig. 7. First and repeat responses to NA and hydrogen 
peroxide. A: the original tracings of the first and repeat 
responses. B: the size of repeat response to NA, the size 
of first contraction induced by NA is equal to 100 %. The 
size of first (painted bar graphs) and repeat (empty bar 
graphs) contraction (C) of arterial fragment after adminis-
tration of different concentrations of hydrogen peroxide.
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Fig. 8. Dose-dependent influence of native CAT on tone 
of arterial fragment after repeat addition of NA and 1.0 
mM hydrogen peroxide. A: the original tracings. B: the 
size of repeat response to NA after addition of different 
concentrations of CAT  (painted bar-graphs), CAT activity 
is equal in twain of comparison. The size of first (painted 
bar-graphs) and second (empty bar-grafs) contraction 
(C) and relaxation (D) of ring arterial fragment to 0.1 mM 
hydrogen peroxide according to CAT activity, (U/ml).90 | ACTA NATURAE |  VOL. 2  № 4 (7)  2010
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and relaxation. At a concentration of 1,000 U/ml the 
CAT effect of 1.0 mM H2O2 decreased to 16% contrac-
tion. CAT displayed a dose-dependent protective effect 
against the stimulation of the vascular fragment by hy-
drogen peroxide. 
Prior incubation of the arterial fragment with CAT 
substantially influenced the invariability of subsequent 
responses to NA and hydrogen peroxide (Fig. 8). At a 
CAT concentration of 100 U/ml and higher the size of 
the second response to NA did not change, whereas in 
the absence of the enzyme it decreased three- or four-
fold (Fig. 8B). The presence of CAT during the first ad-
dition of H2O2 increased the subsequent contractive and 
dilative response (in comparison with the control), and 
when 1,000 U/ml CAT was used the second response 
reliably exceeded the first (Figs. 8C and 8D). Insofar as 
vascular reactions to the repeated effects of NA and 
H2O2 in the absence of CAT decrease significantly, the 
protective function of CAT is obvious. The data re-
ceived after using 0.1 mM H2O2 for 25-500 U/ml CAT 
confirm this conclusion. 
The preventive character of antioxidants implies 
their defensive effect as soon as the physiological level 
of ROS is exceeded. Therefore, we used 0.1 mM H2O2 to 
estimate the comparative effectiveness of the protec-
tive effect of CAT and the SOD-CHS-CAT conjugate in 
our experimental model when testing the invariability 
of vascular functionality (Fig. 9). CAT derivates were 
used in concentrations that were identical in terms of 
CAT activity (U/ml). Native CAT and the SOD-CHS-
CAT conjugate maintained their level of response to 
the secondary addition of NA (Fig. 9B); this addition is 
comparable to the control indicators. In a concentra-
tion range of 25-100 U/ml of catalase activity, the CAT 
and SOD-CHS-CAT derivates demonstrated similar (in 
terms of size) protective effects against 0.1 mM H2O2. At 
a concentration of 500 U/ml, the SOD-CHS-CAT con-
jugate lowered the amplitude response to H2O2 more ef-
fectively than CAT. The protective effect expressed by 
SOD-CHS-CAT may be connected to its affinity to the 
vascular wall (due to the conjugation of SOD with CAT 
via glycosaminoglycan of endothelial glycocalyx [11, 
17]) and/or to the presence of SOD and endogenous NO 
in the model system. In the system described above, it 
is difficult to estimate the sorption of enzyme derivates 
because of the flow of vascular reactions not only from 
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Fig. 9. Comparative effects of protective action of CAT and SOD-CHS-CAT against 0.1 mM hydrogen peroxide. A:  
the original tracings. B: the size of repeat response to NA after the addition of different concentrations of CAT (dark 
bar-graphs) and SOD-CHS-CAT (gray bar-graphs), CAT activity is equal in twain of comparison. C and D:  the contrac-
tion of rat aorta fragment for first (C) and repeat (D) responses to 0.1 mM hydrogen peroxide in the presence (in first 
response) of noted concentration of CAT (left in twain) and SOD-CHS-CAT (right in twain) according to CAT activity 
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within outwards, but also from without inwards (i.e. on 
both the intima and the adventitia) [21]. The defensive 
effect of SOD with regard to NO, however, is possible 
to estimate. 
This effect of native SOD and SOD-CHS-CAT was 
quite pronounced when studied on an NA-preconstrict-
ed arterial fragment (Fig. 10). Both substances caused 
reliable vascular relaxation. This suggests that the ob-
served dilation was determined by the conservation of 
endogenous NO. This is because SOD neutralized the 
superoxide radical capable of turning NO into perox-
ynitrite, which does not have vasodilative properties. 
The experimental evidence of this is the inhibiting ef-
fect of NO-synthase with L-NNA, which caused an in- L-NNA, which caused an in-
crease in vascular tone (Fig. 10C). This effect expresses 
the inhibition of NO-synthase activity and the develop-
ment of a contractive response because of the lack of a 
dilative effect in endogenous NO. The introduction of 
acetylcholine (as an inducer of vascular relaxation by 
means of its effect on the endothelial receptors which 
start off NO-synthase) gave no response, which indi-
cates the effective inhibition of NO-synthase. Against 
the background of L-NNA, the introduction of 10 U/ml 
SOD-activity gave no response. This confirms the role 
of endogenous NO in the vascular relaxation we ob-
served earlier. The introduction of sodium nitroprus-
side (SNP), which acts as an NO donor, caused dilation 
(Fig. 10C); i.e., the vascular fragment did not lose its 
ability to relax under the influence of NO. The increase 
in the bioavailability of NO when the SOD-CHS-CAT 
conjugate was used, similar in size to the effect of na-
tive SOD (Fig. 10A), demonstrates the effectiveness of 
the vasoprotective action of the conjugate, due to the 
activity of its SOD component. 
The bienzyme SOD-CHS-CAT overall reliably dem-
onstrates its vasoprotective qualities that are connected 
to the activity of both of its enzyme components (SOD 
and CAT). These are no less effective than the native 
forms of biocatalysts. This is convincing evidence of the 
SOD-CHS-CAT conjugate’s potential for medicinal de-
velopment. However, its safety and effectiveness need 
to be assessed and proven in vivo.
Vasoactivity of the SOD-CHS-CAT conjugate in vivo
Intravenous bolus injection of varying doses of the 
SOD-CHS-CAT conjugate in rabbits showed that BP 
and HR were changed by no more than 4% relative 
to their average means in intact narcotized animals. 
ECG did not reveal any alterations of the ST-interval, 
rhythm or conductivity disturbances and other abnor-
malities, even when doses of the conjugate 10 times 
greater were administered. Singular intra-abdominal 
injections of SOD-CHS-CAT into BALB/c mice and 
CBAxC57B16 F1-hybrid mice showed a low acute tox-
icity of the conjugate and the absence of mutagenic 
properties, as confirmed through the Ames test. These 
data, together with the high tolerance of the SOD-
CHS-CAT conjugate in animals as was mentioned ear-
lier, as well as its pronounced antithrombotic activity 
[11, 17], justifies the significance of its further inves-
tigation.
The first injection of hydrogen peroxide into rabbits 
(Fig. 11A, curve 1) caused a sharp decrease in BP (up to 
60% of its initial level), which was restored during 10 
minutes in the control group to 90% of its initial level. 
Similar changes were observed in the experimental 
group (Fig. 11A, curve 2). It is noteworthy that the ad-
ministration of the SOD-CHS-CAT derivate 72 hours 
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Fig. 10.  Influence of SOD activity on the tone of arterial fragment. The original tracings after administration of 10 U/ml 
native SOD (A) or SOD-CHS-CAT (B) with NA preconstruction. C: the alteration of vascular tone after administration of 
NA, N-nitro-L-arginine (L-NNA), acetylcholine, native SOD and sodium nitroprusside (SNP), respectively. Alike curves 
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prior to the experiments reliably prevented a drop in 
BP. In that case, we observed only minor initial oscilla-
tions in the BP level followed by smoothening, and the 
stabilization of BP at its initial level (Fig. 11A, curve 3). 
Preventive administration of SOD-CHS-CAT account-
ed for its prophylactic effect in respect to HR in animals 
(Fig. 11B, curve 3) in comparison with data obtained 
in the control (Fig. 11B, curve 1) and the experimental 
(Fig. 11B, curve 2) groups.
Ten minutes after the injection of the conjugate 
(time required for its distribution in the rabbit’s organ-
ism), which did not affect the characteristics of central 
hemodynamics, hydrogen peroxide was injected for 
the second time in a similar concentration and at the 
same rate. The second infusion caused more profound 
changes in BP and HR (Fig. 11). The course of BP re-
covery had two stages – a fast one that took 5 minutes 
and a slow one.
After the administration of SOD-CHS-CAT in the 
animals of the experimental group, the changes in BP 
and HR in response to the injection of the second dose of 
hydrogen peroxide were significantly less pronounced 
and recovery was faster (Fig. 11).
After the first injection of hydrogen peroxide, we did 
not detect any substantial changes in ECG in rabbits, 
although in the control group the ST-segment was low-
ered. The second injection of hydrogen peroxide caused 
the ST-interval to rise, especially in the cases when rab-
bits experienced breathing problems. At 5-8 minutes, 
we observed both isolated and group extrasistoles. The 
first injection of hydrogen peroxide was often accom-
panied by dyspnea, while after the second injection we 
observed hindered breathing and bronchospasms, which 
were more pronounced in the control group.
The first injection of hydrogen peroxide in rats 
caused an initial short-term (no more than 1 minute) 
3-5% increase in BP with a subsequent decrease by 15% 
and full recovery during 10 minutes (Fig. 12A). Under 
these conditions, HR decreased by 3-5% and recov-
ered to up to 96-98% of its initial level during 10 min-
utes (Fig. 12B, curves 1 and 2). Injection of SOD-CHS-
CAT did not affect hemodynamics and ECG in rats. In 
ten minute’s time after the injection of the conjugate 
(time required for its distribution in the rat’s organ-
ism), which did not affect the characteristics of central 
hemodynamics, hydrogen peroxide was injected for 
the second time. The second infusion caused more pro-
found changes in BP and HR as compared to the first 
one. The decrease in BP reached 52% of its initial level 
in the control group and 73% in the experimental group 
(Fig. 12A, curves 1 and 2, respectively, p < 0.05). BP re-
covery in the control group was significantly slower. 
A statistically significant difference in BP recovery in 
both groups was observed in the first minutes.
The shape of the ECG signal was not significantly 
changed, although the number of ventricular extra-
sistols increased in both groups of animals, especially 
after the second injection of hydrogen peroxide.
Thus, the bienzyme SOD-CHS-CAT conjugate was 
shown to significantly prevent changes in the hemo-
dynamics caused by hydrogen peroxide in two animal 
species. The conjugate effectively neglected hydrogen 
peroxide’s direct influence on smooth muscle and car-
diac cells [22], presumably due to the neutralisation of 
both superoxide and H2O2. The effects of SOD-CHS-
CAT were reliably detected before the second injection 
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of hydrogen peroxide, when the antioxidant systems 
were weakened by the first injection of H2O2.
The preventive effect of the SOD-CHS-CAT conju-
gate was more pronounced in animals that were admin-
istered high doses of the conjugate 3 days before the 
experiment. In this case, we observed a full recovery of 
BP and HR after the first injection of H2O2. This is the 
most pronounced antioxidant activity in comparison 
with the other cases considered. It is possible that pre-
ventive administration of the conjugates accounts for 
a more efficient resistance to the action of hydrogen 
peroxide through direct and/or indirect pathways. The 
importance of CAT activity is confirmed by its neces-
sary presence as a component of lecitinized SOD-based 
therapy of bleomycin-induced pulmonary fibrosis in 
mice [23]. The dose-dependence of the therapeutic ef-
fect of lecitinized SOD is described as a bell-shaped 
curve. In the range of high SOD concentrations, the in-
troduction of CAT restores the effect of SOD due to the 
prevention of peroxide accumulation. The presence of 
both SOD and CAT in the enzyme conjugate accounts 
for its antithrombotic activity [9, 17] and normaliza-
tion of BP and HR, which were distorted by hydrogen 
peroxide infusion (Figs. 11 and 12). The effectiveness of 
oral and inhalation administration of a modified form 
of SOD, described in [24] and [23], indicates the impor-
tance of developing oral forms of SOD-CHS-CAT as 
means of preventive antioxidant therapy [25].
CONCLUSIONS 
The results of the present study indicate that supra-
molecular enzymatic conjugates are potentially effec-
tive and safe and that they can be used in practical 
medicine. Covalent cross-linking of enzymatic subu-
nits accounts for a mutual stabilization of  biocatalyst 
activity. Augmented molecular weight and the inclu-
sion of chondroitin sulphate (glycosoaminoglycan of 
the endothelial glycocalyx) in the conjugate results in 
a vasoprotective activity of the SOD-CHS-CAT deri-
vate on the inner surface of the vascular wall. The 
therapeutical effect of the SOD-CHS-CAT is deter-
mined by covalent coupling of SOD and CAT activities, 
which underlies their combined action and formation of 
harmless products of enzymatic conversion. The supra-
molecular structure of the nanoconjugate accounts for 
its previously unknown quality – the capacity to pre-
vent induced platelet aggregation. The activity of the 
components of the SOD-CHS-CAT conjugate is very 
pronounced, since the influence of the SOD and CAT 
activities of the conjugate on the tone of the vascu-
lar fragment is similar to that of  native enzymes. The 
contribution of chondroitin sulphate to the antiaggre-
gational effect is also very clear. The described quali-
ties determine the higher antioxidant activity of the 
SOD-CHS-CAT conjugate, as compared to the other 
combinations of its individual components. The SOD-
CHS-CAT conjugate is well-tolerated, it possesses sat-
isfactorily acute toxicity, normalizing action in relation 
to hemodynamics under oxidative stress, and a pro-
nounced therapeutical effect. All these factors make 
the conjugate a prospective drug candidate. This study 
represents a new approach to the development of ther-
apeutically significant enzymatic conjugates. 
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